You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 165 No. 16, September 12, 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Comments, Opinions, and Brief Case Reports
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (5)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Medical Education
 •Genetics
 •Genetic Counseling/ Testing/ Therapy
 •Genetics, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Ready for Genomic Medicine? Perspectives of Health Care Decision Makers

Arch Intern Med. 2005;165:1917-1919.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Remarkable progress has been made in establishing the field of genomic medicine during the past decade. A host of therapeutic and diagnostic tools—such as the use of molecular simulations to identify new drug pathways1 and gene expression profiles to predict the course of breast cancer2—are moving from the laboratory to the marketplace. Amid the speculation about possible applications and effects of this new medical discipline, 2 major projections have emerged. One predicts that genomic medicine will disrupt many aspects of health care, making current models of its delivery obsolete. Recent reports by the UK National Health Service3 and the US National Human Genome Research Institute4-5 reflect this view. The other is less radical, projecting an initial enhancement of current uses of DNA and genetic information, followed by a gradual diffusion of new genomic medical information and technologies throughout the health care system.6-8

No matter how genomic medicine evolves, it . . . [Full Text of this Article]

Methods


Results

Comment

AUTHOR INFORMATION
Paul R. Billings, MD, PhD; Rick J. Carlson, JD; Josh Carlson, MPH; Mary Cain, MPH; Charles Wilson, MD, MSHA, ScD; Peter Shorett, BA; Wendy Everett, ScD



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Practicing Medicine at the Front Lines of the Genomic Revolution
Wendy S. Rubinstein and Hemant K. Roy
Arch Intern Med. 2005;165(16):1815-1817.
EXTRACT | FULL TEXT  

Genetic Liability to Fractures in the Elderly
Karl Michaëlsson, Håkan Melhus, Helene Ferm, Anders Ahlbom, and Nancy L. Pedersen
Arch Intern Med. 2005;165(16):1825-1830.
ABSTRACT | FULL TEXT  

Prediction of Progression to Cirrhosis by a Glutathione S-Transferase P1 Polymorphism in Subjects With Hereditary Hemochromatosis
Felix Stickel, Christoph H. Österreicher, Christian Datz, Peter Ferenci, Marco Wölfel, Wolfgang Norgauer, Michael R. Kraus, Fritz Wrba, Claus Hellerbrand, and Detlef Schuppan
Arch Intern Med. 2005;165(16):1835-1840.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Guest Editorial: Family Nursing in the Era of Genomic Health Care: We Should Be Doing So Much More!
Van Riper
Journal of Family Nursing 2006;12:111-118.
 

Practicing Medicine at the Front Lines of the Genomic Revolution
Rubinstein and Roy
Arch Intern Med 2005;165:1815-1817.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.